Bortezomib

Information about Bortezomib

Bortezomib uses

Bortezomib is used in the treatment of multiple myeloma and mantle-cell lymphoma.

How bortezomib works

Bortezomib is an anti-cancer medication. It works by blocking or slowing the breakdown of proteins in cells. As a result, there is an increase in a number of proteins in the cancer cells leading to their death.

Common side effects of bortezomib

Low blood platelets, Anemia (low number of red blood cells), Decreased white blood cell count (neutrophils), Fungal infection, Breathlessness, Dehydration, Itching, Dry skin, High blood pressure, Erythema (skin redness), Gastrointestinal bleeding, Decreased white blood cell count (lymphocytes), Herpes zoster, Pneumonia, Lymphopenia, Decreased potassium level in blood, Decreased sodium level in blood, Decreased calcium level in blood, Motor neuropathy, Orthostatic hypotension (sudden lowering of blood pressure on standing), Edema (swelling), Bronchopneumonia, Herpes virus infection, Meningoencephalitis herpetic, Bacteremia, Staphylococcal infection, Coagulation disorder, Swelling of lymph nodes, Angioedema (swelling of deeper layers of skin), Hypersensitivity, Cushing syndrome, Hyperthyroidism, Altered antidiuretic hormone secretion, Tumor lysis syndrome, Diabetes, Fluid retention, Tremors, Peripheral sensorimotor neuropathy, Cerebellar coordination, Balance disorder (loss of balance), Posterior reversible encephalopathy syndrome, Seizure disorders, Speech disorder, Restless legs syndrome, Connective tissue disorders, Cardiac failure, Arrhythmia (irregular heartbeats), Hemorrhage, Inflammation of vein, Pulmonary embolism, Pleural effusion, Bronchospasm, Chronic obstructive pulmonary disease (COPD), Hypoxia (decreased oxygen level in blood), Gastrointestinal obstruction, Irritable bowel syndrome, Hepatitis (viral infection of liver), Cholestasis, Erythema multiforme, Toxic skin eruption, Toxic epidermal necrolysis, Stevens-Johnson syndrome, Psoriasis, Joint inflammation, Urinary tract infection, Renal cell carcinoma, Disseminated intravascular coagulation, Decreased level of thyroid hormones, Gout, Suicidal ideation, Decreased libido, Cerebral hemorrhage, Intracranial bleeding, Transient ischemic attacks, Coma, Guillain-Barré syndrome, Torsade de pointes, Acute respiratory distress syndrome, Pulmonary hypertension (high blood pressure), Pulmonary fibrosis, Interstitial lung disease, Budd-Chiari syndrome, Livedo reticularis, Rhabdomyolysis, Death, Multiple-organ failure

Available Medicine for Bortezomib

  • ₹2787 to ₹4141
    Natco Pharma Ltd
    2 variant(s)
  • ₹2806 to ₹18522
    Dr Reddy's Laboratories Ltd
    2 variant(s)
  • ₹3892 to ₹6246
    Intas Pharmaceuticals Ltd
    3 variant(s)
  • 1 variant(s)
  • ₹1 to ₹54350
    Janssen Pharmaceuticals
    2 variant(s)
  • 1 variant(s)
  • ₹2075
    Panacea Biotec Ltd
    1 variant(s)
  • ₹4315
    Glenmark Pharmaceuticals Ltd
    1 variant(s)
  • ₹5161
    Mylan Pharmaceuticals Pvt Ltd - A Viatris Company
    1 variant(s)
  • ₹2000 to ₹2625
    Celon Laboratories Ltd
    2 variant(s)

Expert advice for Bortezomib

  • Bortezomib is given as an injection into veins or skin under the supervision of a healthcare professional.
  • Do not skip any dose and complete the course as suggested by your doctor.
  • Use an effective method of birth control to avoid pregnancy while taking this medication.
  • You may need to have blood tests to monitor your blood cells, platelets count, liver function and kidney function during treatment.
  • Inform your doctor immediately if you experience coughing, shortness of breath and swelling of feet. 


Content on this page was last updated on 20 June, 2022, by Dr. Varun Gupta (MD Pharmacology)